Chemours Director Courtney Mather Buys 1,401 Deferred Units, Signaling Strong Insider Confidence and a Bullish Outlook for the Company’s Growth Strategy.
Insider Mather’s latest Chemours stock purchase signals confidence in its high‑margin assets and growth strategy—an attractive entry for value investors.
3 minutes to read